AMBUJACEM (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE Clearing Limited levies an additional exposure margin of 15% in the equity derivatives segment on 19 securities where the top 10 clients … | |||||||||||||||
NSE Clearing Limited levies an additional exposure margin of 15% in the equity derivatives segment on 19 securities where the top 10 clients account for more than 20% of MWPL, effective May 29, 2026.
| |||||||||||||||
NSE revises market lots for derivatives contracts on 50 individual stocks effective April 29, 2026, pursuant to SEBI guidelines for periodic … | |||||||||||||||
NSE revises market lots for derivatives contracts on 50 individual stocks effective April 29, 2026, pursuant to SEBI guidelines for periodic lot size revision (SEBI circular dated December 30, 2024).
| |||||||||||||||
NSE Clearing Limited imposes additional exposure margin of 15% in equity derivatives segment on 21 securities where top 10 clients account … | |||||||||||||||
NSE Clearing Limited imposes additional exposure margin of 15% in equity derivatives segment on 21 securities where top 10 clients account for more than 20% of MWPL, effective April 1, 2026.
| |||||||||||||||